Subjects were randomized to receive five weekly injections of 0.05, 0.3, 1, 3, 5 or 8 mg of dulaglutide. At the end of 5 weeks, reductions in FPG were significant (p < 0.05) at all doses except 0. ...

People who have metabolic and bariatric surgery are significantly less likely to develop psychiatric disorders compared to ...

Weight-loss surgery significantly reduces the risk of psychiatric issues like cognitive decline, anxiety, and substance use ...

Long-acting (LA) glucagon-like peptide-1 (GLP-1) receptor agonists (RAs) that require injection once a week ... semaglutide, dulaglutide and ITCA650. Published and preliminary data have shown ...

They were designed to treat diabetes, then prescribed for weight loss, and now—as researchers are finding—they might hold the ...

Experts and organizations call for stricter regulations on how such medications are prescribed – Side effect reports under ...

Bariatric surgery shows better real-life results than GLP-1s in a study: the scalpel achieves five times more weight loss ...

Depending on the specific medication and its form, DMTs may be given orally, by injection, or by infusion. While many injectable DMTs may be self-injected at home, intravenous (IV) and infusion ...

There was also an 8% lower risk of death from any cause among patients taking GLP-1 drugs like Novo Nordisk's Ozempic (semaglutide) and Eli Lilly's Trulicity (dulaglutide) for diabetes and Novo ...

You use the pen to inject the solution under your skin. You can give the injection in your abdomen or the front of your thigh. (A caregiver can also give you an injection in the back of your upper ...

The new oral drug is viewed as a key product for Novo Nordisk as it tries to case Eli Lilly's Trulicity (dulaglutide), a once-weekly GLP-1 drug that is the market leader in the class with sales of ...